Management of Hypertension in Children and Adolescents

Current Cardiology Reports

Volumn 17, Issue 12, 2015, Pages

  Samuels, Joshua ^a,b   Bell, Cynthia ^a   Samuel, Joyce ^a,b   Swinford, Rita ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b MEMORIAL HERMANN HOSPITAL   (United States)

Author keywords

Adolescent; Blood pressure; Hypertension; Pediatric; Pre hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ANTIHYPERTENSIVE AGENT;

ADOLESCENT HEALTH; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CHILD HEALTH CARE; COMORBIDITY; DIAGNOSTIC PROCEDURE; DIET THERAPY; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DRUG INDICATION; ECHOCARDIOGRAPHY; ETHNIC DIFFERENCE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY FUNCTION TEST; LIFESTYLE MODIFICATION; MONOTHERAPY; OBESITY; PRACTICE GUIDELINE; PREHYPERTENSION; PREVALENCE; REVIEW; RISK REDUCTION; ADOLESCENT; CARDIOVASCULAR DISEASES; CHILD; COMPLICATION; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; WEIGHT REDUCTION;

ADOLESCENT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CHILD; HUMANS; HYPERTENSION; OBESITY; PREVALENCE; RISK FACTORS; RISK REDUCTION BEHAVIOR; WEIGHT LOSS;

EID: 84945182189     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-015-0661-1     Document Type: Review

References (58)

1. WHO, World Health Organization. A global brief on hypertension, 2013. Geneva: World Health Organization; 2013.
2. Guo F et al. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;60(7):599–606.
3. Rosner B et al. Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988–2008. Hypertension. 2013;62(2):247–54. This study updates the prevalence of blood pressure abnormalities in US children.
4. Flynn J. The changing face of pediatric hypertension in the era of the childhood obesity epidemic. Pediatr Nephrol. 2013;28(7):1059–66.
5. Lo JC et al. Severe obesity in children: prevalence, persistence and relation to hypertension. Int J Pediatr Endocrinol. 2014;2014(1):3–3.
6. Steinberger J et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2009;119(4):628–47.
7. Shah AS et al. Severe obesity in adolescents and young adults is associated with sub-clinical cardiac and vascular changes. J Clin Endocrinol Metab. 2015: p. jc20144562.
8. de Onis M, Blossner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 2010;92(5):1257–64.
9. Blumenthal S et al. Report of the task force on blood pressure control in children. Pediatrics. 1977;59(5 2 suppl):797–820. p. I-II.
10. Report of the Second Task Force on Blood Pressure Control in Children—1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics, 1987. 79(1): p. 1–25.
11. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics. 1996; 98(4 Pt 1):649–58.
12. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114(2 Suppl 4th Report): 555–76. These remain the official current AAP and NHLBI endorsed guidelines on the diagnosis and treatment of children with hypertension.
13. Thompson M et al. Screening for hypertension in children and adolescents to prevent cardiovascular disease. Pediatrics. 2013;131(3):490–525.
14. McNiece KL et al. Left ventricular hypertrophy in hypertensive adolescents: analysis of risk by 2004 National High Blood Pressure Education Program Working Group staging criteria. Hypertension. 2007;50(2):392–5. This study evaluates cardiovascular end organ damage (LVH and LVMI) in children with varying degrees of abnormal blood pressure.
15. Flynn JT, Falkner BE. The importance of blood pressure screening in children. J Pediatr. 155(2): p. 299.
16. Samuels JA, Bell C, Flynn JT. In reply to gaps in the evidence for screening children for hypertension to prevent adult cardiovascular disease. J Clin Hypertens (Greenwich). 2014;16(1):82.
17. Samuels JA, Bell C, Flynn JT. Screening children for high blood pressure: where the US Preventive Services Task Force went wrong. J Clin Hypertens (Greenwich). 2013;15(8):526–7.
18. Sorof JM. Prevalence and consequence of systolic hypertension in children. Am J Hypertens. 2002;15(2 Pt 2):57S–60.
19. McNiece KL et al. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr. 2007;150(6):640–4. 644 e1.
20. Samuels J. et al. Blood pressure and BMI in school aged children. J Am Soc Neph. 2012. Nov. 2, 2012 Abstract: ASN Annual Meeting.
21. Din-Dzietham R et al. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation. 2007;116(13):1488–96.
22. Ning H et al. Status of cardiovascular health in US children up to 11 years of age: the National Health and Nutrition Examination Surveys 2003–2010. Circ Cardiovasc Qual Outcomes. 2015;8(2):164–71.
23. Muntner P et al. Trends in blood pressure among children and adolescents. JAMA. 2004;291(17):2107–13.
24. Chiolero A et al. Has blood pressure increased in children in response to the obesity epidemic? Pediatrics. 2007;119(3):544–53.
25. Franks PW et al. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med. 2010;362(6):485–93.
26. Flynn JT, Falkner BE. Obesity hypertension in adolescents: epidemiology, evaluation, and management. J Clin Hypertens (Greenwich). 2011;13(5):323–31. This is a good review of primary hypertension in obese adolescents.
27. Daniels SR et al. Sexual maturation and racial differences in blood pressure in girls: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr. 1996;129(2):208–13.
28. Alpert BS, Quinn D, Gallick D. Oscillometric blood pressure: a review for clinicians. J Am Soc Hypertens. 8(12): p. 930–8.
29. Chiolero A, Bovet P, Stergiou GS. Automated oscillometric blood pressure measurement in children. J Clin Hypertens. 2014;16(6):468.
30. Litwin M et al. White coat hypertension in children: not rare and not benign? J Am Soc Hypertens. 2009;3(6):416–23.
31. Sorof JM, Portman RJ. White coat hypertension in children with elevated casual blood pressure. J Pediatr. 2000;137(4):493–7.
32. Piper MA. et al. In: Screening for high blood pressure in adults: a systematic evidence review for the U.S. Preventive Services Task Force. 2014: Rockville.
33. Sorof JM, Portman RJ. Ambulatory blood pressure monitoring in the pediatric patient. J Pediatr. 2000;136(5):578–86.
34. Acosta AA, McNiece KL. Ambulatory blood pressure monitoring: a versatile tool for evaluating and managing hypertension in children. Pediatr Nephrol. 2008;23(9):1399–408.
35. Flynn JT. et al. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension. 2014.
36. Mitsnefes M et al. Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol. 2010;21(1):137–44.
37. Samuels J et al. Ambulatory blood pressure patterns in children with chronic kidney disease. Hypertension. 2012;60(1):43–50.
38. Swartz SJ et al. Cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of hypertension in children. Pediatrics. 2008;122(6):1177–81.
39. Sorof JM et al. Evaluation of white coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Am J Hypertens. 2001;14(9 Pt 1):855–60.
40. Kavey RE et al. White coat hypertension in childhood: evidence for end-organ effect. J Pediatr. 2007;150(5):491–7.
41. Brady TM. Hypertension. Pediatr Rev. 2012;33(12):541–52.
42. Sorof JM et al. Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics. 2004;113(3 Pt 1):475–82.
43. Alp H et al. The effect of hypertension and obesity on left ventricular geometry and cardiac functions in children and adolescents. J Hypertens. 2014;32(6):1283–92.
44. Daniels SR et al. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation. 1998;97(19):1907–11.
45. Davis PH et al. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation. 2001;104(23):2815–9.
46. Brady TM et al. Carotid intima-media thickness in children with CKD: results from the CKiD study. Clin J Am Soc Nephrol. 2012;7(12):1930–7.
47. Expert Panel on Integrated Guidelines for Cardiovascular H et al. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128 Suppl 5:S213–56.
48. Yang Q et al. Sodium intake and blood pressure among US children and adolescents. Pediatrics. 2012;130(4):611–9.
49. Edwards DG, Farquhar WB. Vascular effects of dietary salt. Curr Opin Nephrol Hypertens. 2015;24(1):8–13.
50. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA. 2000: 283(15): 1967–75.
51. Lurbe E et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens. 2009;27(9):1719–42.
52. Ferguson M, Flynn J. Rational use of antihypertensive medications in children. Pediatr Nephrol. 2014;29(6):979–88.
53. Chu PY et al. Anti-hypertensive drugs in children and adolescents. World J Cardiol. 2014;6(5):234–44.
54. Doshi A. FDA Approved pediatric antihypertensive agents. Kidneycentric, 2014. Paper 1. http://digitalcommons.wustl.edu/kidneycentric_all/1.
55. Escape Trial Group et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009;361(17):1639–50.
56. Moyer VA, U.S.P.S.T. Force. Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;159(9):613–9.
57. Kupferman JC et al. Improvement of left ventricular mass with antihypertensive therapy in children with hypertension. Pediatr Nephrol. 2010;25(8):1513–8.
58. Seeman T et al. Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy. Am J Hypertens. 2007;20(9):990–6.